|
PHKA1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.10320000000919E-05 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.145800E-02 |
| Normal-vs-Stage2 |
1.099830E-01 |
| Normal-vs-Stage3 |
1.949730E-02 |
| Normal-vs-Stage4 |
1.595830E-01 |
| Stage1-vs-Stage2 |
3.864600E-01 |
| Stage1-vs-Stage3 |
1.280960E-01 |
| Stage1-vs-Stage4 |
9.643600E-01 |
| Stage2-vs-Stage3 |
7.200800E-01 |
| Stage2-vs-Stage4 |
4.619600E-01 |
| Stage3-vs-Stage4 |
2.022400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.393400E-04 |
| Normal-vs-AfricanAmerican |
1.557220E-01 |
| Normal-vs-Asian |
1.325580E-01 |
| Caucasian-vs-AfricanAmerican |
7.085800E-01 |
| Caucasian-vs-Asian |
2.147400E-01 |
| AfricanAmerican-vs-Asian |
2.707600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.767500E-02 |
| Normal-vs-Female |
6.590200E-04 |
| Male-vs-Female |
6.501900E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.607600E-02 |
| Normal-vs-Extreme_Weight |
5.058000E-01 |
| Normal-vs-Obese |
2.071800E-02 |
| Normal-vs-Extreme_Obese |
2.279000E-01 |
| Normal_Weight-vs-Extreme_Weight |
5.310200E-02 |
| Normal_Weight-vs-Obese |
2.910800E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.321200E-01 |
| Extreme_Weight-vs-Obese |
6.651700E-02 |
| Extreme_Weight-vs-Extreme_Obese |
1.986170E-01 |
| Obese-vs-Extreme_Obese |
9.545400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.142300E-02 |
| Normal-vs-Age(41-60Yrs) |
2.906300E-02 |
| Normal-vs-Age(61-80Yrs) |
4.221400E-03 |
| Normal-vs-Age(81-100Yrs) |
7.332000E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.839000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.747600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.921600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.468000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.942200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.738600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
6.478000E-01 |
| Normal-VS-Type2 PRCC |
6.612600E-04 |
| Normal-VS-KIRP CIMP |
7.320300E-03 |
| Normal-VS-Unclassified PRCC |
7.078300E-03 |
| Type1 PRCC-VS-Type2 PRCC |
5.552000E-04 |
| Type1 PRCC-VS-KIRP CIMP |
2.30679999999595E-05 |
| Type1 PRCC-VS-Unclassified PRCC |
8.609200E-04 |
| Type2 PRCC-VS-KIRP CIMP |
3.577000E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
2.281600E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
9.790400E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.858300E-02 |
| Normal-vs-N1 |
5.638900E-04 |
| Normal-vs-N2 |
1.820180E-01 |
| N0-vs-N1 |
7.043000E-01 |
| N0-vs-N2 |
8.888200E-01 |
| N1-vs-N2 |
9.725400E-01 |
|
|
